Prevest Denpro Limited

BSE: PREVEST · Medical Equipment & Supplies · sector

₹378.95BSE close 2026-10-26

Key numbers

Market cap₹455 cr

Price₹378.95

52w high / low₹550 / ₹318

P/E14.7xSector median 20.2x

P/B4.0xSector median 2.6x

Book value₹94.0

Dividend yield0.26%Sector median 0.24%

ROE29.9%Sector median 12.4%

ROCE36.9%Sector median 13.5%

OPM34.1%Sector median 13.8%

Debt / equity–Sector median 0.13x

EV/EBITDA10.0xSector median 16.4x

Interest cover–

Current ratio14.91x

Sales growth 3y+12.9%Sector median +12.9%

Profit growth 3y+9.3%Sector median +4.1%

PEG1.60x

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 15 companies in Medical Equipment & Supplies (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Other income was 24% of net profit in the last 12 months.
Dividend paid in 3 of the last 5 financial years.
Price ₹378.95 on 2026-10-26: -31.1% from the 52-week high, +19.1% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹654.60 · low ₹360.00

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	33	16	34	18	37	19
EBITDA	12	5	12	6	13	7
OPM %	35.2%	33.7%	34.8%	31.4%	34.0%	35.5%
Other income	2	1	2	1	3	1
Net profit	10	4	10	5	11	6
EPS (₹)	8.06	3.67	8.29	3.93	8.78	4.70
Revenue YoY					+12.0%	+20.9%
Profit YoY					+9.0%	+27.9%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	38	50	56	63	72	109
EBITDA	15	20	20	22	25	37
Net profit	12	16	16	18	20	31
EPS (₹)	9.64	13.09	13.44	15.13	17.07	25.70
Revenue growth		+32.5%	+13.2%	+11.7%	+13.9%	–
Profit growth		+35.8%	+2.6%	+12.7%	+12.8%	–
Dividend / share (₹)	–	–	1.00	1.00	1.00

Compounded growth	3 years	5 years	Last 12 months
Sales	+12.9%	–	–
Net profit	+9.3%	–	–
EPS	+9.3%	–	–
Share price	–	-13.8% (2y)	-23.5%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	94	113
Cash & equivalents	66	82
Total assets	113	133
Fixed assets	27	27
Investments	0	0
Inventory	8	11

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	15	15
Cash from investing	-1	-2
Cash from financing	-1	-1
Capex	2	2
Free cash flow	13	13

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	19.4%	18.2%
ROCE %	25.9%	24.5%
Inventory days	239	239
Working capital days	462	505

Peers in Medical Equipment & Supplies

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
POLYMED	₹14,631 cr	46.4x	4.7x	10.7%	12.7%	22.8%	+18.9%	0.24%
MOLBIO	₹14,360 cr	–	–	–	–	–	–	–
TARSONS	₹1,587 cr	142.7x	2.5x	1.8%	4.1%	26.8%	+14.3%	–
LAXMIDENTL	₹945 cr	30.4x	3.9x	13.7%	13.4%	14.0%	–	–
FISCHER	₹856 cr	11.2x	2.2x	-0.8%	11.6%	13.6%	–	0.04%
HSIL	₹740 cr	36.9x	6.5x	21.8%	24.1%	10.0%	–	–
FABTECH	₹543 cr	8.8x	1.3x	11.6%	13.6%	10.9%	–	–
PREVEST	₹455 cr	14.7x	4.0x	29.9%	36.9%	34.1%	+12.9%	0.26%
NURECA	₹296 cr	63.0x	1.6x	2.5%	5.3%	3.5%	+9.7%	–
CHOKSI	₹115 cr	22.2x	2.7x	13.1%	17.9%	14.5%	+300.1%	–

All 15 companies in Medical Equipment & Supplies →

Dividends & corporate actions

Ex-date	Action	Detail
2026-09-04	Dividend	Final Dividend Rs 1.0
2025-09-03	Dividend	Final Dividend Rs 1.0
2024-08-30	Dividend	Final Dividend Rs 1.0
2023-08-23	Dividend	Final Dividend Rs 1.0

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Medical Equipment & Supplies
Sub-industry	Medical Equipment & Supplies
Symbol	PREVEST
BSE code	543363
ISIN	INE0GAO01018
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.